Single-cell sequencing-guided discovery of narciclasine as a dual VCAM-1/ICAM-1 inhibitor for atherosclerosis management.
- DOI
- 10.1016/j.gendis.2026.102167
- Published
- 2027 Jan
- Container
- Genes & diseases
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.gendis.2026.102167,
title = {Single-cell sequencing-guided discovery of narciclasine as a dual VCAM-1/ICAM-1 inhibitor for atherosclerosis management.},
author = {Wang Y and Cao Z and Lan H and Li B and Wang G and Chen Q},
year = {2027},
journal = {Genes \& diseases},
doi = {10.1016/j.gendis.2026.102167},
url = {https://doi.org/10.1016/j.gendis.2026.102167}
}RIS
TY - JOUR TI - Single-cell sequencing-guided discovery of narciclasine as a dual VCAM-1/ICAM-1 inhibitor for atherosclerosis management. AU - Wang Y AU - Cao Z AU - Lan H AU - Li B AU - Wang G AU - Chen Q PY - 2027 JO - Genes & diseases DO - 10.1016/j.gendis.2026.102167 UR - https://doi.org/10.1016/j.gendis.2026.102167 ER -
APA
Y, W., Z, C., H, L., B, L., G, W., & Q, C. (2027). Single-cell sequencing-guided discovery of narciclasine as a dual VCAM-1/ICAM-1 inhibitor for atherosclerosis management.. Genes & diseases. https://doi.org/10.1016/j.gendis.2026.102167
Source records
- pubmed · retrieved 2026-09-26T02:25:16.058Z